{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:54:22Z","timestamp":1792655662925,"version":"4.5.0"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.1001\/jamasurg.2021.3655","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T11:02:53Z","timestamp":1629284573000},"page":"1001","source":"Crossref","is-referenced-by-count":169,"title":["Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa"],"prefix":"10.1001","volume":"156","author":[{"given":"Falk G.","family":"Bechara","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology, and Allergology, St Josef Hospital, Ruhr-University Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Podda","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical Center Klinikum Darmstadt, Teaching Hospital Goethe-University Frankfurt, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol P.","family":"Prens","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Women\u2019s College Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joslyn","family":"Kirby","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Geng","sequence":"additional","affiliation":[{"name":"AbbVie Inc, North Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Jean","sequence":"additional","affiliation":[{"name":"AbbVie Inc, North Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor B. E.","family":"Jemec","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Zealand University Hospital, Roskilde, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany"},{"name":"Department of Venereology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany"},{"name":"Department of Allergology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany"},{"name":"Department of Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"soi210055r1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa.","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"soi210055r2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1524-4725.2011.02186.x","article-title":"Hidradenitis suppurativa: surgical and other management techniques.","volume":"38","author":"Ellis","year":"2012","journal-title":"Dermatol Surg"},{"issue":"2","key":"soi210055r3","first-page":"114","article-title":"What is hidradenitis suppurativa?","volume":"63","author":"Lee","year":"2017","journal-title":"Can Fam Physician"},{"issue":"5","key":"soi210055r4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000507323","article-title":"Medical and surgical management of hidradenitis suppurativa: a review of international treatment guidelines and implementation in general dermatology practice.","volume":"236","author":"Orenstein","year":"2020","journal-title":"Dermatology"},{"key":"soi210055r5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-5945-12-9","article-title":"A review of wide surgical excision of hidradenitis suppurativa.","volume":"12","author":"Alharbi","year":"2012","journal-title":"BMC Dermatol"},{"issue":"1","key":"soi210055r6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management.","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"soi210055r7","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8018192","article-title":"Review of current immunologic therapies for hidradenitis suppurativa.","volume":"2017","author":"Shanmugam","year":"2017","journal-title":"Int J Rheumatol"},{"issue":"5","key":"soi210055r9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa.","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"soi210055r10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaad.2018.05.040","article-title":"Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa\/acne inversa: 3-year results of a phase 3 open-label extension study.","volume":"80","author":"Zouboulis","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"soi210055r11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial.","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"issue":"2","key":"soi210055r12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/bjd.2011.165.issue-2","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"soi210055r13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/ijd.2018.57.issue-1","article-title":"Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy.","volume":"57","author":"Shanmugam","year":"2018","journal-title":"Int J Dermatol"},{"issue":"2","key":"soi210055r14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/SAP.0000000000000584","article-title":"Outcomes after combined radical resection and targeted biologic therapy for the management of recalcitrant hidradenitis suppurativa.","volume":"77","author":"DeFazio","year":"2016","journal-title":"Ann Plast Surg"},{"issue":"10","key":"soi210055r15","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/jdv.v33.10","article-title":"Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study.","volume":"33","author":"Prens","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"20","key":"soi210055r16","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"soi210055r17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/09546634.2017.1341614","article-title":"Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.","volume":"29","author":"Kimball","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"soi210055r18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management.","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"soi210055r19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jdv.2019.33.issue-1","article-title":"Hidradenitis suppurativa\/acne inversa: a practical framework for treatment optimization\u2014systematic review and recommendations from the HS ALLIANCE working group.","volume":"33","author":"Zouboulis","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"soi210055r20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa.","volume":"17","author":"Gulliver","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"soi210055r21","first-page":"38","article-title":"Adalimumab in conjunction with surgery in patients with moderate to severe hidradenitis suppurativa: baseline characteristics from a phase 4, double-blind, randomized, placebo-controlled study.","volume":"29","author":"Bechara","year":"2020","journal-title":"Exp Dermatol"},{"issue":"5","key":"soi210055r22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/bjd.v181.5","article-title":"Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.","volume":"181","author":"Jemec","year":"2019","journal-title":"Br J Dermatol"},{"key":"soi210055r23","first-page":"37","article-title":"Efficacy and safety results from the SHARPS Study: phase 4, randomized, controlled trial of adalimumab plus surgery in moderate-to-severe hidradenitis suppurativa.","volume":"29","author":"Bechara","year":"2020","journal-title":"Exp Dermatol"},{"key":"soi210055r24","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2147\/JPR","article-title":"Immune function after major surgical interventions: the effect of postoperative pain treatment.","volume":"11","author":"Amodeo","year":"2018","journal-title":"J Pain Res"},{"issue":"4","key":"soi210055r25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5114\/ceji.2014.47741","article-title":"The immune response to surgery and infection.","volume":"39","author":"Dabrowska","year":"2014","journal-title":"Cent Eur J Immunol"},{"issue":"5","key":"soi210055r26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of hidradenitis suppurativa.","volume":"14","author":"von der Werth","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"soi210055r27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40257-017-0341-6","article-title":"Safety of adalimumab dosed every week and every other week: focus on patients with hidradenitis suppurativa or psoriasis.","volume":"19","author":"Ryan","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"soi210055r8","unstructured":"Humira. Accessed June 30, 2021. https:\/\/www.humira.com\/"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2783257\/jamasurgery_bechara_2021_oi_210055_1636049347.71866.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T19:28:27Z","timestamp":1636572507000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2783257"}},"subtitle":["The SHARPS Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2021.3655","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}